Loading stock data…
AptarGroup, Inc. (ATR)
$124.34-3.07 (-2.41%)
After Hours$124.34+0.00 (+0.00%)· Last close Sep 8
AptarGroup, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
AptarGroup, Inc. in the Healthcare sector is trading at $124.34 with a market capitalization of $8.7B. Wall Street consensus targets $170.14 (7 analysts), implying a +36.8% move over the next 12 months. The stock is currently 15% below its 52-week high of $146.91, remaining 1.1% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 25 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +36.8% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 25) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $982.87M↑ | $962.74M↑ | $961.13M↓ | $966.01M |
| Gross Profit | — | $351.91M↑ | $338.22M↓ | $363.08M↓ | $367.01M |
| Operating Income | — | $108.58M↓ | $110.32M↓ | $139.09M↓ | $145.97M |
| Net Income | — | $72.67M↓ | $74.34M↓ | $127.93M↑ | $111.72M |
Peer Comparison
JNJUNHPFE
Fundamentals
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and bever...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.69B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
24.68
Beta
Defensive asset. Lower volatility than the S&P 500.
0.38
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.54%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.46%
Volume
Today's trading volume
362,192
Recent News
WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?
West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.
WST Gains 15.3% in Three Months as HVP Growth Strengthens Outlook
WST's HVP growth, wider margins and raised 2026 outlook support its recent rally, but a premium valuation raises the bar for further gains.
AptarGroup Q2 Earnings Beat Estimates on Pharma & Beverage Growth
ATR tops Q2 earnings and revenue estimates as pharma and beverage growth lift quarterly revenues above $1B for the first time despite margin pressure.
Why AptarGroup (ATR) International Revenue Trends Deserve Your Attention
Review AptarGroup's (ATR) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
AptarGroup Inc (ATR) (Q2 2026) Earnings Call Highlights: Record Sales and Strategic Wins Amid ...
All three segments post growth with record quarterly revenue, but margin declines and operational challenges in beauty and closures temper the outlook.